http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2557103-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85f07c75f85d843baf29f4a3379c3f2f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
filingDate 1983-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bb6f7ff13bf77046021c977fcba77ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44bfc4884234ca3d21bfb4f4ab8eb06a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09d1bea0005324763c9372c645a218e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123980eb9477cef9f71cf3a38b5bce63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bea3f4dffbeb74ca80a018c6ef3db52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8057386bb71d17f3d2627135a011b0b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ebefa9f57679d64f815efaac436753c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b2e55f2270b61db52dcb21d6e8e9c09
publicationDate 1985-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2557103-A1
titleOfInvention NOVEL CYCLOALKYLAMINO-1 TERTIOBUTYLAMINO-3 PROPANOLS-2, THEIR PREPARATION METHOD AND THEIR THERAPEUTIC APPLICATION
abstract THE PRESENT INVENTION CONCERNS NEW CYCLOALKYLAMINO-1 TERTIOBUTYLAMINO-3 PROPANOLS-2 OF GENERAL FORMULA: (CF DRAWING IN BOPI) IN WHICH N REPRESENTS AN ENTIRE WHOLE MAY TAKE ANY OF THE VALUES BETWEEN 6 AND 11; THESE PRODUCTS MAY BE IN THE FORM OF FREE BASE OR PHARMACEUTICALLY ACCEPTABLE SALTS. THESE PRODUCTS ARE GENERALLY PREPARED IN TWO STEPS: THE AMINE IS REACTED: (CF DRAWING IN BOPI) (OR N REPRESENTS A WHOLE THAT CAN TAKE ANY OF THE VALUES BETWEEN 6 AND 11) AND EPICHLORHYDRINE: ( CF DRAWING IN BOPI) IN A SOLVENT, THEN THE EPOXIDE CHLORYDRATE SO OBTAINED WITH TERTIOBUTYLAMINE, IN A SOLVENT SUCH AS ETHANOL AT THE SOLVENT'S BOILING TEMPERATURE. THE PRODUCTS ACCORDING TO THE PRESENT INVENTION ARE USEFUL THERAPEUTICALLY IN PARTICULAR AS ANTIMICROBIALS.
priorityDate 1983-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100736
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1772
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2903
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415805831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID573
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1351
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419769253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410524400

Total number of triples: 48.